{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:13Z","timestamp":1740106933925,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00277-023-05133-5","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T21:33:06Z","timestamp":1676323986000},"page":"889-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-636X","authenticated-orcid":false,"given":"Mohammad","family":"Ammad Ud Din","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moazzam","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hania","family":"Liaqat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pinilla-Ibarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jaglal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"unstructured":"American Cancer Society. Cancer Facts & Figures 2022 2022. Available from: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2022.html.\u00a0Accessed 12 Nov 2022","key":"5133_CR1"},{"issue":"10","key":"5133_CR2","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00277-021-04600-1","volume":"100","author":"N Alrawashdh","year":"2021","unstructured":"Alrawashdh N, Sweasy J, Erstad B, McBride A, Persky DO, Abraham I (2021) Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985\u20132017). Ann Hematol 100(10):2501\u20132512","journal-title":"Ann Hematol"},{"key":"5133_CR3","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3389\/fonc.2019.01435","volume":"9","author":"B Fattizzo","year":"2019","unstructured":"Fattizzo B, Barcellini W (2019) Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects. Front Oncol 9:1435","journal-title":"Front Oncol"},{"issue":"5","key":"5133_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2141.2008.07086.x","volume":"141","author":"CS Zent","year":"2008","unstructured":"Zent CS, Ding W, Schwager SM, Reinalda MS, Hoyer JD, Jelinek DF et al (2008) The prognostic significance of cytopenia in chronic lymphocytic leukaemia\/small lymphocytic lymphoma. Br J Haematol 141(5):615\u2013621","journal-title":"Br J Haematol"},{"issue":"4","key":"5133_CR5","first-page":"257","volume":"5","author":"W Ding","year":"2007","unstructured":"Ding W, Zent CS (2007) Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia\/ small lymphocytic lymphoma. Clin Adv Hematol Oncol 5(4):257\u2013261","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"5133_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1538-7836.2004.01052.x","volume":"3","author":"A Tomer","year":"2005","unstructured":"Tomer A, Koziol J, McMillan R (2005) Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors. J Thromb Haemost 3(1):74\u201378","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5133_CR7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1182\/blood-2007-09-111492","volume":"111","author":"C Visco","year":"2008","unstructured":"Visco C, Ruggeri M, Laura Evangelista M, Stasi R, Zanotti R, Giaretta I et al (2008) Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood 111(3):1110\u20131116","journal-title":"Blood"},{"issue":"5","key":"5133_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/1097-0142(197305)31:5<1092::AID-CNCR2820310509>3.0.CO;2-B","volume":"31","author":"SE Jones","year":"1973","unstructured":"Jones SE (1973) Autoimmune disorders and malignant lymphoma. Cancer 31(5):1092\u20131098","journal-title":"Cancer"},{"issue":"5","key":"5133_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.leu.2404592","volume":"21","author":"C Visco","year":"2007","unstructured":"Visco C, Giaretta I, Ruggeri M, Madeo D, Tosetto A, Rodeghiero F (2007) Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia. Leukemia 21(5):1092\u20131093","journal-title":"Leukemia"},{"issue":"11","key":"5133_CR10","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1080\/1042819031000119235","volume":"44","author":"F Zaja","year":"2003","unstructured":"Zaja F, Vianelli N, Sperotto A, Patriarca F, Tani M, Marin L et al (2003) Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. Leuk Lymphoma 44(11):1951\u20131955","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"5133_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.10369","volume":"74","author":"MJ Kyasa","year":"2003","unstructured":"Kyasa MJ, Parrish RS, Schichman SA, Zent CS (2003) Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia\/small lymphocytic lymphoma\u2020. Am J Hematol 74(1):1\u20138","journal-title":"Am J Hematol"},{"unstructured":"HCUP-US NIS Overview. Available from: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp.\u00a0Accessed 12 Nov 2022","key":"5133_CR12"},{"unstructured":"Trend weights for HCUP NIS Data. Available from: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/trendwghts.jsp.\u00a0Accessed 12 Nov 2022","key":"5133_CR13"},{"issue":"2","key":"5133_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3171\/2015.12.JNS151107","volume":"126","author":"HH Dasenbrock","year":"2017","unstructured":"Dasenbrock HH, Yan SC, Gross BA, Guttieres D, Gormley WB, Frerichs KU et al (2017) The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. J Neurosurg 126(2):537\u2013547","journal-title":"J Neurosurg"},{"issue":"16","key":"5133_CR15","doi-asserted-by":"publisher","first-page":"e025839","DOI":"10.1161\/JAHA.121.025839","volume":"11","author":"S Zahid","year":"2022","unstructured":"Zahid S, Khan MZ, Gowda S, Faza NN, Honigberg MC, Vaught AJ et al (2022) Trends, predictors, and outcomes of cardiovascular complications associated with polycystic ovary syndrome during delivery hospitalizations: a National Inpatient Sample Analysis (2002\u20132019). J Am Heart Assoc 11(16):e025839","journal-title":"J Am Heart Assoc"},{"key":"5133_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.amjcard.2020.12.031","volume":"143","author":"W Ullah","year":"2021","unstructured":"Ullah W, Zahid S, Hamzeh I, Birnbaum Y, Virani SS, Alam M (2021) Trends and predictors of transcatheter aortic valve implantation telated in-hospital mortality (from the National Inpatient Sample Database). Am J Cardiol 143:97\u2013103","journal-title":"Am J Cardiol"},{"key":"5133_CR17","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2017-05-784876","volume":"130","author":"AJHT Kumar","year":"2017","unstructured":"Kumar AJHT, Rodday AM, Parsons SK (2017) Longer length of stay and no chemotherapy is associated with greater likelihood of death during hospitalization in patients with diffuse large B-cell lymphoma: an analysis from the National Inpatient Sample (NIS). Blood. 130:2121","journal-title":"Blood."},{"issue":"1","key":"5133_CR18","first-page":"80","volume":"25","author":"LF Diehl","year":"1998","unstructured":"Diehl LF, Ketchum LH (1998) Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25(1):80\u201397","journal-title":"Semin Oncol"},{"issue":"3","key":"5133_CR19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1182\/blood-2007-09-111492","volume":"111","author":"C Visco","year":"2008","unstructured":"Visco C, Ruggeri M, Laura Evangelista M, Stasi R, Zanotti R, Giaretta I et al (2008) Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood 111(3):1110\u20131116","journal-title":"Blood"},{"key":"5133_CR20","doi-asserted-by":"publisher","first-page":"100621","DOI":"10.1016\/j.ijcha.2020.100621","volume":"31","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty S, Faisaluddin M, Ashish K, Amgai B, Bandyopadhyay D, Patel N et al (2020) In-hospital clinical outcomes of transcatheter aortic valve replacement in patients with concomitant carotid artery stenosis: insights from the national inpatient sample. IJC Heart Vasc 31:100621","journal-title":"IJC Heart Vasc"},{"issue":"6","key":"5133_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/14779072.2021.1924678","volume":"19","author":"S Zahid","year":"2021","unstructured":"Zahid S, Ullah W, Khan MU, Abbas S, Ud Din MT, Uddin MF et al (2021) Trends, predictors, and outcomes of major bleeding after transcatheter aortic valve implantation, from national inpatient sample (2011\u20132018). Expert Rev Cardiovasc Ther 19(6):557\u2013563","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"5133_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","volume":"94","author":"H Frederiksen","year":"1999","unstructured":"Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94(3):909\u2013913","journal-title":"Blood"},{"issue":"22","key":"5133_CR23","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","volume":"124","author":"G Moulis","year":"2014","unstructured":"Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L (2014) Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood 124(22):3308\u20133315","journal-title":"Blood"},{"issue":"12","key":"5133_CR24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ajh.22170","volume":"86","author":"M Michel","year":"2011","unstructured":"Michel M, Rauzy OB, Thoraval FR, Languille L, Khellaf M, Bierling P et al (2011) Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study. Am J Hematol 86(12):980\u2013984","journal-title":"Am J Hematol"},{"issue":"1","key":"5133_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/trf.15069","volume":"59","author":"R Goel","year":"2019","unstructured":"Goel R, Chopra S, Tobian AAR, Ness PM, Frank SM, Cushing M et al (2019) Platelet transfusion practices in immune thrombocytopenia related hospitalizations. Transfusion 59(1):169\u2013176","journal-title":"Transfusion"},{"issue":"15","key":"5133_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1056\/NEJMoa2110297","volume":"386","author":"DJ Kuter","year":"2022","unstructured":"Kuter DJ, Efraim M, Mayer J, Trn\u011bn\u00fd M, McDonald V, Bird R et al (2022) Rilzabrutinib, an oral BTK inhibitor, in immune thrombocytopenia. N Engl J Med 386(15):1421\u20131431","journal-title":"N Engl J Med"},{"issue":"Supplement 1","key":"5133_CR27","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1182\/blood-2021-144691","volume":"138","author":"T Yu","year":"2021","unstructured":"Yu T, Wang L, Ni X, Hou Y, Liu X, Hou M (2021) Orelabrutinib, a selective Bruton\u2019s tyrosine kinase (BTK) inhibitor in the treatment of primary immune thrombocytopenia (ITP). Blood. 138(Supplement 1):3172","journal-title":"Blood."},{"issue":"12","key":"5133_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/aje\/kwh314","volume":"160","author":"SR Heckbert","year":"2004","unstructured":"Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A et al (2004) Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women\u2019s Health Initiative. Am J Epidemiol 160(12):1152\u20131158","journal-title":"Am J Epidemiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05133-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T21:27:38Z","timestamp":1678397258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05133-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["5133"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05133-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Javier Pinilla-Ibarz received research grant from SecuraBio and consultancy fee from AstraZeneca, AbbVie, Pharmacyclics, Janssen Pharmaceuticals. Michael Jaglal received consultancy fee from Novartis. Mohammad Ammad Ud Din, Amir Mahmud, Mariam Mostafa, Moazzam Shahzad, and Hania Liaqat declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}